Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $18.00 | |||
| Open | $4.05 | 52 Week Low | $6.91 | |||
| Day High | $4.05 | P/E | N/A | |||
| Day Low | $4.05 | EPS | $-0.67 | |||
| Volume | 410 | |||||
